Correlation between base-excision repair gene polymorphisms and levels of in-vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yu, Hongping ^a,b   Zhao, Hui ^b   Wang, Li E ^b   Liu, Zhensheng ^b   Li, Donghui ^b   Wei, Qingyi ^b  

^a School of Public Health   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; DIHYDROXYBENZO[A]PYRENE OXIDE; DNA; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GLUTAMIC ACID; GLYCINE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; VALINE; XRCC1 PROTEIN;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; APEX1 GENE; ARTICLE; CANCER RISK; CAUCASIAN; CELL TRANSFORMATION; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; EPSTEIN BARR VIRUS; EXCISION REPAIR; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; MALE; NORMAL HUMAN; PARP1 GENE; PERIPHERAL LYMPHOCYTE; VOLUNTEER; XRCC1 GENE;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADULT; AGED; CELL LINE; CELLS, CULTURED; DNA ADDUCTS; DNA REPAIR; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

HUMAN HERPESVIRUS 4;

EID: 84863620704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040131     Document Type: Article

References (65)

1. Peltonen K, Dipple A, (1995) Polycyclic aromatic hydrocarbons: chemistry of DNA adduct formation. J Occup Environ Med 37: 52-58.
2. Li C, Liu Z, Wang LE, Strom SS, Lee JE, et al. (2006) Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 27: 1894-1901.
3. Benhamou S, Sarasin A, (2000) Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 462: 149-158.
4. O'Brien TJ, Brooks BR, Patierno SR, (2005) Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells. Mol Cell Biochem 279: 85-95.
5. McHugh PJ, Spanswick VJ, Hartley JA, (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol 2: 483-490.
6. Abbotts R, Madhusudan S, (2010) Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer. Cancer Treat Rev 36: 425-435.
7. Houtgraaf JH, Versmissen J, van der Giessen WJ, (2006) A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 7: 165-172.
8. Baute J, Depicker A, (2008) Base excision repair and its role in maintaining genome stability. Crit Rev Biochem Mol Biol 43: 239-276.
9. Wilson DM 3rd, Bohr VA (2007) The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) 6: 544-559.
10. Nemec AA, Wallace SS, Sweasy JB, (2010) Variant base excision repair proteins: contributors to genomic instability. Semin Cancer Biol 20: 320-328.
11. Li H, Ha TC, Tai BC, (2009) XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 18: 183-191.
12. Tudek B, (2007) Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 28: 258-275.
13. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, et al. (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18: 204-214.
14. Yosunkaya E, Kucukyuruk B, Onaran I, Gurel CB, Uzan M, et al. (2010) Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg 24: 561-565.
15. Wang M, Qin C, Zhu J, Yuan L, Fu G, et al. (2010) Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol 29: 303-311.
16. Jin XM, Kim HN, Lee IK, Park KS, Kim HJ, et al. (2010) PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males. BMC Med Genet 11: 38.
17. Zhao H, Wang LE, Li D, Chamberlain RM, Sturgis EM, et al. (2008) Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Carcinogenesis 29: 1560-1566.
18. Braithwaite E, Wu X, Wang Z, (1998) Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 19: 1239-1246.
19. Blakey DH, Douglas GR, (1990) The role of excision repair in the removal of transient benzo[a]pyrene-induced DNA lesions in Chinese hamster ovary cells. Mutat Res 236: 35-41.
20. Day RS 3rd, Scudiero D, Dimattina M (1978) Excision repair by human fibroblasts of DNA damaged by r-7, t-8-dihyroxy-t-9,10-oxy-7,8,9,10- tetrahydrobenzo(a)pyrene. Mutat Res 50: 383-394.
21. Van Houten B, Masker WE, Carrier WL, Regan JD, (1986) Quantitation of carcinogen-induced DNA damage and repair in human cells with the UVR ABC excision nuclease from Escherichia coli. Carcinogenesis 7: 83-87.
22. Casale GP, Singhal M, Bhattacharya S, RamaNathan R, Roberts KP, et al. (2001) Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem Res Toxicol 14: 192-201.
23. Stierum RH, van Herwijnen MH, Hageman GJ, Kleinjans JC, (1994) Increased poly(ADP-ribose) polymerase activity during repair of (+/-)-anti-benzo[a]pyrene diolepoxide-induced DNA damage in human peripheral blood lymphocytes in vitro. Carcinogenesis 15: 745-751.
24. Li D, Firozi PF, Chang P, Wang LE, Xiong P, et al. (2001) In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer 93: 436-440.
25. Li D, Wang LE, Chang P, El-Naggar AK, Sturgis EM, et al. (2007) In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res 67: 5628-5634.
26. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007.
27. Shekari M, Sobti RC, Tamandani DM, Malekzadeh K, Kaur P, et al. (2008) Association of genetic polymorphism of the DNA base excision repair gene (APE-1 Asp/148 Glu) and HPV type (16/18) with the risk of cervix cancer in north Indian population. Cancer Biomark 4: 63-71.
28. Deng Q, Sheng L, Su D, Zhang L, Liu P, et al. (2011) Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol.
29. Li Z, Guan W, Li MX, Zhong ZY, Qian CY, et al. (2011) Genetic Polymorphism of DNA Base-excision Repair Genes (APE1, OGG1 and XRCC1) and Their Correlation with Risk of Lung Cancer in a Chinese Population. Arch Med Res 42: 226-234.
30. Ali MF, Meza JL, Rogan EG, Chakravarti D, (2008) Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol Rep 19: 1033-1038.
31. Consortium IH, (2003) The International HapMap Project. Nature 426: 789-796.
32. Holm K, Melum E, Franke A, Karlsen TH, (2010) SNPexp- A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11: 600.
33. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
34. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, et al. (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25: 2433-2441.
35. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, et al. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15: 353-358.
36. Wei Q, Spitz MR, (1997) The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev 16: 295-307.
37. Bonn D, (1998) How DNA-repair pathways may affect cancer risk. Lancet 351: 42.
38. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92: 1764-1772.
39. Helzlsouer KJ, Harris EL, Parshad R, Fogel S, Bigbee WL, et al. (1995) Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int J Cancer 64: 14-17.
40. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L, (1993) DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 90: 1614-1618.
41. Hall J, English DR, Artuso M, Armstrong BK, Winter M, (1994) DNA repair capacity as a risk factor for non-melanocytic skin cancer-a molecular epidemiological study. Int J Cancer 58: 179-184.
42. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L, (1994) DNA repair and susceptibility to basal cell carcinoma: a case-control study. Am J Epidemiol 140: 598-607.
43. Wei Q, Cheng L, Hong WK, Spitz MR, (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res 56: 4103-4107.
44. Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, et al. (2010) Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res 30: 1359-1364.
45. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, et al. (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631: 101-110.
46. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, et al. (2009) A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 18: 223-229.
47. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27: 560-567.
48. Cheng SC, Hilton BD, Roman JM, Dipple A, (1989) DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. Chem Res Toxicol 2: 334-340.
49. Weinstein IB, Jeffrey AM, Jennette KW, Blobstein SH, Harvey RG, et al. (1976) Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science 193: 592-595.
50. Meehan T, Straub K, (1979) Double-stranded DNA steroselectively binds benzo(a)pyrene diol epoxides. Nature 277: 410-412.
51. Osborne MR, Jacobs S, Harvey RG, Brookes P, (1981) Minor products from the reaction of (+) and (-) benzo[a]-pyrene-anti-diolepoxide with DNA. Carcinogenesis 2: 553-558.
52. Osborne M, Merrifield K, (1985) Depurination of benzo[a]pyrene-diolepoxide treated DNA. Chem Biol Interact 53: 183-195.
53. Alexandrov K, Rojas M, Satarug S, (2010) The critical DNA damage by benzo(a)pyrene in lung tissues of smokers and approaches to preventing its formation. Toxicol Lett 198: 63-68.
54. Jeffrey AM, Grzeskowiak K, Weinstein IB, Nakanishi K, Roller P, et al. (1979) Benzo(a)pyrene-7,8-dihydrodiol 9,10-oxide adenosine and deoxyadenosine adducts: structure and stereochemistry. Science 206: 1309-1311.
55. Straub KM, Meehan T, Burlingame AL, Calvin M, (1977) Identification of the major adducts formed by reaction of benzo(a)pyrene diol epoxide with DNA in vitro. Proc Natl Acad Sci U S A 74: 5285-5289.
56. Devanesan PD, RamaKrishna NV, Todorovic R, Rogan EG, Cavalieri EL, et al. (1992) Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem Res Toxicol 5: 302-309.
57. Van Houten B, (1990) Nucleotide excision repair in Escherichia coli. Microbiol Rev 54: 18-51.
58. Hess MT, Gunz D, Luneva N, Geacintov NE, Naegeli H, (1997) Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol Cell Biol 17: 7069-7076.
59. King HW, Osborne MR, Brookes P, (1979) The in vitro and in vivo reaction at the N7-position of guanine of the ultimate carcinogen derived from benzolalpyrene. Chem Biol Interact 24: 345-353.
60. Luo M, He H, Kelley MR, Georgiadis MM, (2010) Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal 12: 1247-1269.
61. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR, (2009) The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 11: 601-620.
62. Manvilla BA, Varney KM, Drohat AC, (2010) Chemical shift assignments for human apurinic/apyrimidinic endonuclease 1. Biomol NMR Assign 4: 5-8.
63. Evans AR, Limp-Foster M, Kelley MR, (2000) Going APE over ref-1. Mutat Res 461: 83-108.
64. Kelley MR, Parsons SH, (2001) Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1. Antioxid Redox Signal 3: 671-683.
65. Fritz G, (2000) Human APE/Ref-1 protein. Int J Biochem Cell Biol 32: 925-929.